The marked parathyroid hyperplasia in FHH1 or NSHPT might be caused both by the less effective CaSR and by loss of the anti-proliferative function of 1,25D3 due to mutated CaSR. The gene discussed is CASR; the disease is neonatal severe primary hyperparathyroidism.